Study identifies risk factors for ‘long-haul’ COVID-19 in people with rheumatic diseases

A new study by researchers at Hospital for Special Surgery (HSS) in New York City demonstrates over half of patients with rheumatic diseases who contracted COVID-19 during the pandemic and completed a COVID-19 survey, experienced so-called “long-haul” COVID, or prolonged symptoms of the infection, including loss of taste or smell, muscle aches and difficulty concentrating, for one month or longer.
Did you miss our previous article…
https://www.integurx.net/?p=141